Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

• Príomhchruthaitheoirí: Randall Severance (Údar), Howard Schwartz (Údar), Ron Dagan (Údar), Laurie Connor (Údar), Jianing Li (Údar), Alison Pedley (Údar), Jonathan Hartzel (Údar), Tina M. Sterling (Údar), Katrina M. Nolan (Údar), Gretchen M. Tamms (Údar), Luwy K. Musey (Údar), Ulrike K. Buchwald (Údar), for the V114-021 (PNEU-FLU) (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Streptococcus pneumoniae and influenza viruses are associated with significant morbidity and mortality in older adults. Concomitant vaccination against these agents reduces hospitalization and mortality rates. This phase 3 trial evaluated safety, tolerability, and immunogenicity of concomitant and n...